The challenges of the expanded availability of genomic information: an agenda setting-paper

Rapid advances in microarray and sequencing technologies are making genotyping and genome sequencing more affordable and readily available. There is an expectation that genomic sequencing technologies improve personalized diagnosis and personalized drug therapy. Concurrently, provision of direct-to-...

Full description

Bibliographic Details
Main Author: Borry, P. (author)
Other Authors: Bentzen, H. B. (author), Budin-Ljøsne, I. (author), Cornel, M. C. (author), Howard, H.C. (author), Feeney, O. (author), Jackson, L. (author), Mascalzoni, D. (author), Mendes, A. (author), Peterlin, B. (author), Riso, B. (author), Shabani, M. (author), Skirton, H. (author), Sterckx, S. (author), Vears, D. F. (author), Wjst, M. (author), Felzmann, H. (author)
Format: article
Language:eng
Published: 2018
Subjects:
Genomics
Clinical and research genomic data
Return of results
Data sharing
Informed consent
Direct-to-consumer genetic testing
Online Access:http://hdl.handle.net/10071/15379
Country:Portugal
Oai:oai:repositorio.iscte-iul.pt:10071/15379

Internet

http://hdl.handle.net/10071/15379

Similar Items